1. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and independent human xenograft models;Agus;Cancer Res,1999
2. Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostate;Amato;Urol Oncol,1995
3. The microtubule-affecting drug paclitaxel has antiangiogenic activity;Belotti;Clin Cancer Res,1996
4. Loss of cell cycle control allows selective microtubule-active drug-induced bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells;Blagosklonny;Cancer Res,2000
5. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death;Blagosklonny;Cancer Res,1997